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Ability of Video Telemetry to Predict
Unplanned Hospital Admissions for Single
Ventricle Infants
Doaa M. Aly , MBBCH, MSc; Lori A. Erickson , PhD, MSN, RN, CPNP-PC; Hayley Hancock
Jonathan W. Apperson, BS; Monica Gaddis, PhD; Girish Shirali, MBBS; Suma Goudar, MD

, MD;

BACKGROUND: Our Cardiac High Acuity Monitoring Program (CHAMP) uses home video telemetry (HVT) as an adjunct to
monitor infants with single ventricle during the interstage period. This study describes the development of an objective early
warning score using HVT, for identification of infants with single ventricle at risk for clinical deterioration and unplanned hospital
admissions (UHA).
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METHODS AND RESULTS: Six candidate scoring parameters were selected to develop a pragmatic score for routine evaluation of
HVT during the interstage period. We evaluated the individual and combined ability of these parameters to predict UHA. All infants with single ventricle monitored at home by CHAMP between March 2014 and March 2018 were included. Videos obtained
within 48 hours before UHA were compared with videos obtained at baseline. We used binary logistic regression models and
receiver operating characteristic curves to evaluate the parameters’ performance in discriminating the outcome of interest.
Thirty-nine subjects with 64 UHA were included. We compared 64 pre-admission videos to 64 paired baseline videos. Scoring
was feasible for a mean of 91.6% (83.6%–98%) of all observations. Three different HVT score models were proposed, and a
final model composed of respiratory rate, respiratory effort, color, and behavior exhibited an excellent discriminatory capability with an area under the receiver operating characteristic curve of 93% (89%–98%). HVT score of 5 was associated with
specificity of 93.8% and sensitivity of 88.7% in predicting UHA.
CONCLUSIONS: We developed a feasible and reproducible HVT score that can serve as a tool to predict UHA in infants with
single ventricle. Future directions involve prospective, multicenter validation of this tool.
Key Words: early warning score ■ interstage ■ monitoring ■ single ventricle ■ telemedicine ■ univentricular heart

P

atients with single ventricle (SV) congenital heart disease remain at increased mortality risk, particularly
during the interstage period; between the first and
second palliative surgical stages. Despite the steadily
improving survival to hospital discharge after the initial
neonatal surgery, the incidence of death before stage II
palliation remains at ≈10% to 12%.1–4 Interstage home
monitoring programs involving daily parental surveillance
of parameters such as daily weight and oxygen saturations, have significantly improved interstage survival.5–14
Cardiac High Acuity Monitoring Program
(CHAMP) is an advanced form of interstage home

monitoring which we developed at our institution, with the goal of standardizing management
during this critical period. CHAMP is a tablet/smart
phone-b ased application that incorporates symptoms, vital signs, and video telemetry.15 It provides
secure, and nearly instantaneous transfer of patient information to a cloud-b ased server for immediate analysis and communication by the clinical
management team. Since the implementation of
this program in 2014, we have witnessed a significant reduction in interstage mortality from 17%14
to ~3%.16 The additive role of video telemetry to
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CLINICAL PERSPECTIVE
What Is New?

• Cardiac High Acuity Monitoring Program is an
advanced form of interstage home monitoring
that incorporates symptoms, vital signs, and
video telemetry.
• The additive role of video telemetry to home
monitoring has not been previously studied.

What Are the Clinical Implications?

• This study provides a highly accurate, feasible,
and reproducible early warning scoring system,
utilizing home video telemetry, for prediction of
unplanned hospital admissions in single ventricle infants.
• Having a structured approach to video telemetry can increase healthcare providers’ confidence and comfort level with this type of virtual
care.

Nonstandard Abbreviations and Acronyms
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AUROC area under the receiver operating
characteristics
BT
Blalock Taussig
CHAMP Cardiac High Acuity Monitoring Program
EWS
early warning score
HVT
home video telemetry
SV
single ventricle
UHA
unplanned hospital admission

home monitoring has not been previously studied.
This is particularly relevant as the COVID-19 pandemic has forced all healthcare systems to rapidly implement telehealth services. In the midst
of “stay at home” orders and physical distancing
measures, a structured approach to video telemetry can increase healthcare providers’ confidence
and comfort level with this type of virtual care,
while minimizing out-of-h ome exposures for at-r isk
populations.
While several early warning scores (EWS) are currently available for bedside prediction of cardiac arrest
and/or unplanned intensive care unit transfer of general and cardiac pediatric patients, 17–19 data on the
early identification of sick infants at home by video telemetry are still lacking. The primary aim of this study
was to develop a systematic EWS system using home
video telemetry (HVT) to identify SV interstage infants
at risk for clinical deterioration and predict unplanned
hospital admission (UHA).

METHODS
Study Design and Participants
The data that support the findings of this study are
available from the corresponding author upon reasonable request. A single center, cohort study, with retrospective analysis of CHAMP HVT was conducted.
Infants enrolled in the CHAMP from March 2014 to
March 2018 were considered eligible for the study. As
reported in an earlier study,16 these included all infants
with shunt-
dependent SV physiology, patients with
aorto-pulmonary shunts in anticipation of biventricular repair, patients with pulmonary artery banding and
anticipated single ventricle palliation, and patients with
stable neonatal physiology, with undetermined candidacy for biventricular repair. Patients had to have at
least 5 videos during the entire period of monitoring
and at least 1 UHA were included. Ethics approval
was granted by the Institutional Review Board for the
Protection of Human Subjects. Waiver of informed
consent/assent was provided because of the retrospective nature of this study.

Home Video Telemetry
As a special feature of CHAMP, parents are instructed
to record 15-second-long video clips of their infant
at least once a day for routine surveillance, using the
CHAMP device camera. These clips are transferred
via cellular network to the CHAMP team through the
CHAMP app, for later viewing (asynchronous HVT).
Daily review and subjective assessment of the videos is performed by the clinical management team,
which at our institution, includes dedicated registered
nurse coordinators, advance practice nurses, and
cardiologists.

HVT Score Development
To test the additive value of HVT in detecting imminent
clinical deterioration among SV interstage infants, we
developed an HVT based EWS that can be used to
trigger critical evaluation of those patients. A multidisciplinary planning panel, including pediatric cardiologists, nurse practitioners, and software architects with
significant involvement in CHAMP was set for development of the HVT score.
Since no similar video scoring systems exist, we
modeled the HVT score after the previously established Pediatric Early Warning Score.17 Pediatric
Early Warning Score is a validated in-hospital bedside tool for early detection of clinical deterioration
and prevention of cardiopulmonary arrests or unplanned transfers to the intensive care unit.17 Our
planning panel identified the risk factors unique to
infants with SV as well as markers of severity of clinical derangement.
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Significant concern

Mild concern

<20 or ≥70
4

Severe subcostal retractions, head
bobbing, paradoxical breathing

Irritable, difficult to console
Gray

Gray and mottled
3

Suprasternal/intercostal retractions

50 to 59

60 to 69

2

Moderate subcostal retractions, flaring

Lethargic, floppy, reduced response to
stimulation or pain

Wound infection concerns (erythema/
swelling/discharge) or rash
Sleepy, somnolent when not disturbed
Pale
40 to 49
1

Mild subcostal retractions

No wound concern/rash
Playing/sleeping appropriately,
baseline activity, smiling, and tracking
parents
Pink or mild
cyanosis
No accessory muscle use, no retractions

Color
Respiratory Effort
Respiratory
Rate
Score

Table 1. The Home Video Telemetry Score for Single Ventricle Interstage Infants
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As with Pediatric Early Warning Score, our HVT scorecard includes objective assessment of 3 domains:
respiratory, cardiovascular, and neurologic. Our initial
score included every possible visible parameter belonging to each of these domains (Table 1). Additionally,
skin, specifically surgical wound status, was included
as it was felt to be of clinical relevance to postoperative
cardiac patients. Finally, appearance was included to
indicate staff’s overall subjective clinical impression of
the patient’s condition compared to the typical, healthy
single ventricle patient.
For individual parameters, observations were scored
from 0 to 4, with higher scores indicating increasing
level of concern (Table 1). Skin was dichotomous for
the presence or absence of rash and/or infection and
appearance was graded as expected, mild concern or
significant concern. The initial HVT score ranged from
0 to 17.
Unplanned hospital admission (UHA) was considered an objective indicator of clinical deterioration and
was used as the primary outcome. Hospital admissions were considered unplanned when unrelated to
planned procedural or surgical intervention or diagnostic imaging.
Before implementation, 2 pediatric cardiologists
(D.A., H.H.) received extensive education and training
on how to apply the HVT score to CHAMP videos.
Training was provided by a front-line advanced practice nurse (L.E.) who uses CHAMP videos daily for triaging and patient care. Inter-rater reproducibility of the
HVT score was established between both physicians
in a sample of 30 videos. Both raters were masked to
the date and time of the videos.
To assess the HVT score’s ability to discriminate
the outcome of interest, we compared HVT scores of
videos obtained within 48 hours before the UHA (pre-
admission) to those obtained at baseline. Baseline
status was defined as the period within 48 hours post-
discharge from a UHA or post-neonatal (stage I palliation) discharge.

Behavior

Score Parameters

20 to 39

Skin

Appearance

A special challenge we faced during the development of our HVT score was that all score parameters
of interest had to be visible to be remotely assessed.
Therefore, variables such as heart rate, rhythm, and
capillary refill had to be replaced with visible parameters. Also, and unlike the Children’s Early Warning
Score; a modification to the Pediatric Early Warning
Score by Children’s Hospital of Boston,20 we did not
incorporate “families’ concerns” since we aimed for
our clinical score to be based on objective assessment
of the videos rather than on familiarity with the patient’s
history. This specific parameter is separately evaluated
within CHAMP as a “red flag warning”.

Expected
appearance

Home Video Telemetry and Single Ventricle Infants

0
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Randomization and Masking of Raters
An independent member of the planning panel (L.E.),
who was not involved in scoring the videos, used chart
review to identify patients eligible for inclusion and
dates of their UHAs. Computer-
generated random
selection of the videos was performed within the predefined timeframes. Selected videos were deidentified
and subsequently inserted into a password encrypted
database. Videos were scored by the primary investigator (D.A.) who was masked to date of the videos
and admission status attached to the videos (baseline
versus pre-admission).

Statistical Analysis
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Statistical analysis was performed using SPSS for
Windows version 26.0 (SPSS, Inc., Chicago, IL, USA).
Data were presented as means±SD and percentages,
as appropriate. We compared the individual HVT score
parameters as well as total composite scores for the
same UHA, between pre-
admission and baseline.
Kolmogorov‒Smirnov test was used to test for normality, and outliers were eliminated after being detected
by box plots.
Given the dependent nature of data, we used
paired samples t-
tests to compare means among
continuous data and Wilcoxon signed-rank test for
non-parametric data. A P value of <0.05 was considered significant. We used the receiver operating
curves to evaluate the discriminant capability of the
total score and individual parameters independently
to identify UHA. An area under the receiver operating
curves (AUROC) of one indicated perfect discrimination, and 0.5 reflected a discriminating capability no
better than chance.
We then used binary logistic regression to assess the
individual contribution of each candidate score parameter to predict UHA. The results were presented as odds
ratios and 95% CI. Multicollinearity between the individual scoring parameters was assessed using Pearson
correlation coefficient (r), variance inflation factor and
tolerance values. The final HVT score was generated
through forced entry regression. Inter-rater reproducibility was assessed using intra-class coefficients.

RESULTS
Patient Characteristics and Unplanned
Hospital Admissions
One hundred and two patients were enrolled in CHAMP
during the study period. Thirty-nine patients (38% of the
CHAMP cohort) with 64 UHAs were included (Table 2).
Forty-one patients who had UHAs were excluded because of lack of videos within 48 hours of a readmission
(n=35), or submission of <5 videos during the entire

Home Video Telemetry and Single Ventricle Infants

Table 2. Demographic and Unplanned Hospital Admission
Characteristics
Patients, n=39

n (%)

Sex
Women

17 (43.6)

Men

22 (56.4)

Anatomy
HLHS

16 (41.0)

Other*

23 (59.0)

Type of palliation
Norwood RV/PA shunt

10 (25.6)

Norwood BT shunt

7 (18)

Hybrid

3 (7.7)

BT shunt

9 (23)

PA band

5 (13)

Others

†

5 (13)

Unplanned hospital admissions, n=64
Age at admission (days)

133.2±85

ICU admissions

34 (53)

No. of ICU days

7.4±10.0

Unplanned cardiac surgery

8 (12.5)

Glenn palliation

2

PA band

3

DKS/shunt

1

Sternal wound debridement

1

BT shunt revision
Unplanned cardiac catheterization

1
7 (11)

Coarctation balloon angioplasty

4

DKS balloon angioplasty

1

BT stent angioplasty

1

BAS

1

Mortality

1

BAS indicates balloon atrial septostomy; BT, Blalock Taussig; DKS,
Damus-Kaye-Stansel; HLHS, hypoplastic left heart syndrome; ICU, intensive
care unit; PA, pulmonary artery; and RV, right ventricle.
*Other indicates unbalanced atrioventricular canal, borderline left sided
structures, double inlet left ventricle, tricuspid atresia.
†
Others indicates PDA stent, RV/PA shunt, none.

period of monitoring (n=6). Twenty-two patients were
excluded because of lack of UHA. Forty-three percent
of the study cohort had Norwood stage 1 palliation.
Thirty-six of the 64 UHAs were preceded by red flags.
The most common indication for UHA was desaturation
(n=24, 37%) followed by feeding intolerance (n=16, 25%)
(Figure 1). Nearly 50% of UHAs included admissions
to the intensive care unit, either directly or as a transfer from the regular care cardiac unit. Eight unplanned
cardiac surgeries and 7 unplanned cardiac catheterizations were performed during these UHAs. There was a
single mortality after experiencing cardiac arrest in an
outside hospital; this patient died after 21 days of veno-
arterial extracorporeal membrane oxygenation.
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Figure 1. Pie chart showing the different indications for unplanned hospital admissions in
interstage single ventricle infants.

Reproducibility and Feasibility of Video
Telemetry Scoring
Downloaded from http://ahajournals.org by on August 18, 2021

and baseline videos. Five of the parameters (respiratory rate, respiratory effort, color, behavior, and appearance) and the composite scores were significantly
higher for the pre-admission videos than for the baseline videos (Table 3), while the difference in the proportion of skin rash and or infection was not statistically
significant between the 2 groups (P=0.23).
The results of receiver operating curve analysis are
presented in (Table 4). An HVT score with all the parameters included had an excellent discriminating capability with an AUROC of 0.95. Individual score parameters
had AUROC values between 0.71 (for respiratory effort)
and 0.82 (for color). Skin had poor discriminating capability with AUROC of 0.5, P>0.05.

Total of 128 videos were included for scoring, including 64 pre-admission videos and 64 baseline videos
(paired for the corresponding UHA). The inter-
rater
reproducibility was excellent for most individual score
parameters with an intra-class coefficient >0.85 (with
the exception of skin; intra-class coefficients, 0.71) and
for composite scores. Video scoring was feasible for
91.6% of all observations, with a feasibility rate ranging
between 83.6% and 98% for each individual score parameter. Color had the highest non-scorable percentage at 16%. Observations were deemed non-scorable
and were eventually excluded from analysis because of
reasons such as inadequate lighting or distance from
the patient, excessive movement, or inadequate exposure of body/skin with clothing or other coverings.

Predictors of Unplanned Hospital
Admissions During the Interstage Period
Logistic regression analysis was conducted to assess
whether a score model based on the candidate parameters could accurately predict UHA. The assumptions of linearity, independence of errors, and absent

Discriminant Analysis of the HVT Score
Individual HVT score parameters as well as the composite scores were compared between pre-admission

Table 3. Comparative Analysis of Means/Medians of the Individual HVT Score Items and Composite Score
Video type

Respiratory rate

Respiratory effort

Color

Behavior

Skin

Appearance

Composite score

Pre-admission

2.6

2.5

1

1

0

2

7

Baseline

1.2

1

0

0

0

0

2

P value

0.009*

0.004*

0.0007*

0.005*

0.23

0.0009*

0.0001*

Means of respiratory rate, respiratory effort, color, and composite score were compared using paired sample t-test.
Medians of behavior, skin, and appearance were compared using Wilcoxon signed-rank test.
*P value of <0.05 (statistically significant).
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4-predictor linear regression binary model (model 3);
Cox and Snell R2=0.6 and Nagelkerke R2=0.72.
Finally, we compared the AUROC between the
3 models (Table 6 and Figure 2) and the final model
(model 3) continued to have excellent discriminant capability with a mean AUROC of 0.93 (0.89–0.98). An
HVT score of 5 had a specificity of 93.8% and sensitivity of 88.7% (Figure 2).

Table 4. AUROC for the Initial HVT Score and Individual
Candidate Score Variable
Variables

AUROC

SE

P Value

95% CI

HVT score

0.95

Respiratory rate

0.73

0.016

0.003*

0.93‒0.99

0.05

0.0001*

Respiratory effort

0.64‒0.8

0.71

0.045

0.009*

0.62‒0.79

Color

0.82

0.04

0.0006*

0.74‒0.89

Behavior

0.75

0.04

0.004*

0.66‒0.83

Skin

0.5

0.05

0.184

0.45‒0.66

Appearance

0.8

0.03

0.0002*

0.79‒0.92

DISCUSSION

AUROC indicates area under the receiver operating curve; HVT, home
video telemetry; and SE, standard error.
*P value of <0.05 (statistically significant).
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multicollinearity were tested. A significant correlation
was noted between appearance and each of the respiratory effort, color, and behavior parameters with an
r of 0.8, 0.75 and 0.79, respectively. The contribution
of each parameter to the score model was also tested.
Table 5 displays the odds ratios of each parameter.
Skin again was found to be of insignificant predictive
value, with a P value for the Wald test >0.05. The parameters that contributed the most to the model were
color (odds ratio [OR], 8.32; P value <0.005) and respiratory effort (OR, 4.5; P value <0.002).
Based on those results, 3 different models were
generated and tested: model 1; with all the variables included, model 2; with skin eliminated and model 3; with
skin and appearance eliminated (the latter was eliminated because of significant collinearity with other variables). Likelihood ratios were compared, and model fits
were evaluated by performing the Hosmer-Lemeshow
test and also compared between the 3 models (Table 6).
The final model (model 3); composed of respiratory
rate, respiratory effort, color, and behavior, showed significant prediction of UHA with Chi-square (X2)=100.8,
df=4, P<0.05. This was slightly lower than that of the
first and second models; X2=111.4 and 110.5 respectively (Table 6). Approximately 60% to 72.3% of the variance in the outcome of UHA can be predicted from this

We have successfully developed a clinical scoring
system for HVT that can identify SV interstage infants
at risk for clinical deterioration and predict UHA. To
our knowledge, this is the first study to provide systematic assessment of the role of HVT in interstage
home monitoring. To summarize our results, an HVT
score based on respiratory rate, respiratory effort,
color, and behavior provides excellent prediction of
UHA (X 2=100.8, df=4, P<0.05) and significant discriminatory capability between preadmission and baseline
daily videos (mean AUROC, 0.93). A cut-off of 5 out of
13 has a specificity of 93.8% and sensitivity of 88.7%
predicting UHA. Finally, this HVT score system is feasible and highly reproducible among different raters.
SV interstage infants often experience acute physiologic deterioration shortly before suffering adverse
events such as cardiac arrest or death at home. These
events are potentially preventable by timely recognition
of patients’ derangement and proper management by
a skilled team. While home monitoring programs have
been associated with improved interstage mortality13
(possibly because of successful prediction of gradual
clinical worsening), an acute “track and trigger” tool
is still lacking. Our CHAMP clinical team have used
their subjective impressions based on HVT, however,
a pragmatic, objective tool for systematic assessment
of HVT is still missing. This can be vital to newly trained
physicians and nurses when subtle clinical changes
may not be evident unless quantified.

Table 5. Variables Included in the HVT Score Model
Variables

B

SE

Wald Test

P Value

Odds Ratio

95% CI

Respiratory rate

1.72

0.38

8.61

0.003*

3.6

2.97‒5.36

Respiratory effort

1.5

0.48

9.61

0.002*

4.5

1.7‒11.67
2.6‒26.59

Color

2.11

0.59

12.78

<0.0005*

8.32

Behavior

1.23

0.42

8.38

0.004*

3.43

1.49‒7.9

Skin

0.72

0.75

0.91

0.339

2.06

0.46‒9.14

Appearance

1.23

0.45

7.57

0.006*

3.45

1.42‒8.33

Constant

−4.9

0.99

25.17

<0.005

0.007

B indicates beta coefficient; and SE, standard error.
*P value of <0.05 (statistically significant).
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Table 6.
Models

Home Video Telemetry and Single Ventricle Infants

Likelihood Ratios and AUROC Analysis of the Three Generated Models
Chi-square (x2)

df

AUROC

SE

P Value

95% CI

Model 1

111.4

6

0.95

0.19

0.003*

0.91‒0.99

Model 2

110.5

5

0.95

0.19

0.0001*

0.91‒0.98

Model 3

100.78

4

0.93

0.02

0.00002*

0.89‒0.98

AUROC indicates area under of the receiver operatory; df, degree of freedom; and SE, standard error.
* P value of <0.05 (statistically significant).

It is worth mentioning that only 36 of 64 UHAs in
our study were preceded by red flags, suggesting a
maximum sensitivity of red flags of 56%, and indicating
higher sensitivity of our HVT score (88.7%) in detecting
SV interstage infants at risk than relying on red flags
alone. While this tool was designed and completed
before the emergence of the coronavirus pandemic,
we believe that the need for this tool has particularly
increased now as healthcare providers are currently
striving to provide the best quality virtual care to their
critical patients, with limited in-person evaluation.

Development of the HVT Early Warning
Score
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The current study detailed the development of an objective and easy to use early warning score model. We
started by including all possible visible indicators of
the cardiorespiratory status as recommended by our
CHAMP multidisciplinary team. This was followed by

reproducibility testing, comparative, and predictive analysis of individual HVT parameters. This helped us determine which parameters should be included. We then
confirmed the discriminating capability of our final model
and the sensitivity and specificity of an optimal composite
score threshold. This multi-phased approach (Figure 3)
has been previously used in developing risk assessment
tools21 and refining previously established EWS.22
The “appearance” parameter was initially included as a
subjective impression of deterioration. In our study, despite the significantly higher mean score of this parameter before admission than at baseline and high AUROC,
significant overlap (collinearity) was noted with other
parameters. Therefore, we propose that appearance is
a cumulative impression that a reviewer may develop
based on his/her assessment of other parameters. With
this amount of overlap and subjectivity we decided to
remove this parameter from our final model.
Another interesting parameter we investigated
was skin. In our cohort, only 5 pre-admission home

Figure 2. Receiver operating curves for the 3 models.
ROC indicates receiver operating characteristic curves.
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Figure 3. Flow diagram summarizing the steps of development of our home video telemetry
score.
HVT indicates home video telemetry.

videos raised suspicion for wound infection. This was
not unexpected, given the relatively low rate of wound
infections beyond the immediate postoperative hospitalization. Therefore, it is possible that our cohort was
under-powered for this parameter. A larger sample size
may be required to confidently confirm the lack of contribution of the skin parameter to the outcome.
When all parameters were combined, 3 different
models were generated. While all 3 models had relatively similar discriminating capabilities (Figure 2), we
opted to remove the 2 aforementioned parameters
(appearance and skin) when generating our final model
for simplification. Jarvis and co-
authors23 demonstrated that simpler EWS with less parameters can
help reduce the risk of errors and unnecessary effort
and time, leading to more reliable scores for identical
performance.
Scoring HVT was feasible with 91.6% of observations being scorable. This reflects the high quality of
videos obtained and can be attributed to the detailed
instructions and extensive training parents receive before discharge by our CHAMP coordinators, as well as

the high resolution of technology involved in capturing
those videos and online data transmission.

HVT Future Directions
While still a relatively new tool, a small body of literature
on HVT is developing. This is particularly relevant in
the COVID era. In the field of neurology, HVT has been
increasingly used for ictal capture and for prolonged
monitoring of patients with epilepsy for precise localization of their epileptic foci.24 A recent pediatric study by
Carlson et al. demonstrated similar diagnostic efficacy
and study quality of HVT and inpatient video telemetry and a higher parental preference for HVT versus
inpatient video telemetry (76% versus 31%).25 In the
field of infectious disease, a recently published multicenter double-masked, randomized trial in 22 clinics in
England, demonstrated more effective observation of
tuberculosis treatment by smart phone enabled HVT
than by direct observation therapy.26
Future intentions include extending this study to a
larger cohort across different centers in a prospective
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manner. This will help us validate the positive contribution of HVT to home monitoring of interstage SV infants.
The use of machine learning to automate the detection
of features of interest is also one of our goals. While
the cohort of infants with SV has been the center of
the CHAMP project and this study, we have been interested in collaborating with our colleagues from other
cardiac subspecialties to study the role of home monitoring in general and HVT in particular, in other vulnerable pediatric cardiac populations such as infants with
post-cardiac transplant and arrhythmia. Finally, consideration for caregivers’ comfort level with digital/virtual
technology, preference, and satisfaction should also be
studied.

Limitations
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Our study is limited by its retrospective and single
center nature. CHAMP has been successfully deployed in 9 additional pediatric heart centers with
a total of 610 patients enrolled, and it is our intention to validate this tool in a prospective multicenter
study through collaboration with these centers.
This should be followed by a pilot implementation
and audit before more extended adoption in routine
practice. Our study was at risk for selection (information) bias which was minimized by performing
a computer-
based randomization of the selected
videos and masking the rater to all possible patient
identifiers as well as video status (pre-admission versus baseline). Confounding bias, where our outcome
of interest (UHA) might be potentially explained by a
systematic overlap between the score variables is a
possibility, although this was specifically examined
by using correlation coefficients and variance inflation factor. Our HVT score experience is specific to
interstage SV infants and may not be generalizable
to other populations. This study is underpowered
for the outcomes of unplanned surgical or catheter-
based intervention and death. Finally, the incremental value of HVT to other CHAMP parameters such
as oxygen saturation, intake, and output was not assessed in this study.

CONCLUSIONS
We developed an objective EWS using HVT for prediction of acute physiologic derangement prompting
UHA in interstage SV infants. Prospective, multicenter
validation of this tool followed by pilot implementation
and audit is needed before extended adoption in the
routine clinical care of these high-risk infants.
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